A multi-institutional research group led by researchers from Tokyo Medical and Dental University (TMDU) has made a significant and promising step forward in our ability to treat human immunodeficiency virus type 1 (HIV-1), the virus underlying acquired immunodeficiency syndrome (AIDS).
New Weapon Shows Promise in HIV Fight miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researchers from Tokyo Medical and Dental University (TMDU) have identified a compound that can efficiently reactivate latent HIV-1 in humancells: compound 2, a derivative of a molecule called YSE028. Reactivation of latent HIV-1 alongside the use of antiretroviral agents to treat active viruses is a potential treatment strategy for HIV, but effective latency reversing agents are lacking. This novel compound provides the potential for effective new HIV therapies.
Team identifies molecular compound that shows promise in the fight against HIV medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been devastating the entire world. While the vaccination program is advancing, drug treatments for COVID-19 are still highly important for those who become infected.